Since the CD158a receptor recognizes HLA class I molecules, it would be interesting to study HLA class I tumor cell expression in primary colorectal tumors to investigate whether there is an association with the presence of circulating CD158a+ NKT-like immune cells. This evidence concerns the gene KIR2DL1 and neoplasm.